Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pulmatrix Inc (NASDAQ:PULM)

2.64
Delayed Data
As of May 26
 -0.1363 / -4.90%
Today’s Change
0.50
Today|||52-Week Range
6.98
+348.25%
Year-to-Date
No recent news for Pulmatrix Inc.

Today’s Trading

Previous close2.78
Today’s open2.78
Day’s range2.57 - 2.82
Volume316,287
Average volume (3 months)3,939,430
Market cap$50.4M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+41.80%
Earnings growth (this year)+50.53%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.47%
P/E ratioNM
Price/Sales10.47
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.00-0.12%
TTNPTitan Pharmaceutical...-0.05-2.08%
TCONTRACON Pharmaceutica...0.000.00%
ITEKInotek Pharmaceutica...0.000.00%
Data as of 3:59pm ET, 05/26/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$835.0K
Annual profit (last year)-$27.8M
Net profit margin-3,334.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert W. Clarke
Chief Financial Officer, Treasurer &
Secretary
William E. Duke
Corporate headquarters
Lexington, Massachusetts

Forecasts